Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
Bioengineering (Basel, Switzerland)|October 27, 2022
A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin SubunitsYu Zeng, Mengqiu Jiang, Sally Robinson, et al.Frontiers in Psychiatry|December 22, 2022
Case report: Advice for schools on managing functional tic-like behavioursTamsin Owen, Juliana Silva, Claire Grose, et al.Molecular Plant-Microbe Interactions : MPMI|November 6, 2007
The lipid lysyl-phosphatidylglycerol is present in membranes of Rhizobium tropici CIAT899 and confers increased resistance to polymyxin B under acidic growth conditionsChristian Sohlenkamp, Kanaan A Galindo-Lagunas, Ziqiang Guan, et al.Journal of Pharmacological and Toxicological Methods|September 25, 2012
Reducing suffering in animal models and procedures involving seizures, convulsions and epilepsySarah Wolfensohn, Penny Hawkins, Elliot Lilley, et al.Toxicology|August 5, 2017
The current status of exposure-driven approaches for chemical safety assessment: A cross-sector perspectiveFiona Sewell, Manoj Aggarwal, Gerald Bachler, et al.Movement Disorders Clinical Practice|March 27, 2024
Intense Imagery Movements May Lead to Maladaptive Daydreaming: A Case Series and Literature ReviewTammy Hedderly, Claire Eccles, Osman Malik, et al.Regulatory Toxicology and Pharmacology : RTP|August 23, 2011
Opportunities to minimise animal use in pharmaceutical regulatory general toxicology: a cross-company reviewSusan S Sparrow, Sally Robinson, Sue Bolam, et al.Experimental Cell Research|March 4, 2014
Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironmentJong-Hyuk Kim, Aric M Frantz, Katie L Anderson, et al.Regulatory Toxicology and Pharmacology : RTP|April 23, 2013
A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studiesKathryn Chapman, Fiona Sewell, Linda Allais, et al.Regulatory Toxicology and Pharmacology : RTP|February 26, 2008
A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug developmentSally Robinson, Jean-Luc Delongeas, Elizabeth Donald, et al.Pageof 7